CapitalBio Corporation
Biochips, high throughput screening, disease diagnostics, pharmagenomics
The company was founded on 30 September 2000 by Tsinghua University, Huazhong University of Science and Technology, Chinese Academy of Medical Sciences and Academy of Military Medical Sciences.
Jing Cheng (CEO, CTO)
Keith Mitchelson (VP, International Business Development and Marketing)
Liye Zhou (Chairman)
18 Life Science Parkway, Changping District,
Beijing, 102206
P.R. China
Phone: +86-10-80715888 or -80726868
Fax: +86-10-80726898
CapitalBio Hybrisker™
CapitalBio™ 4-Phase AC Signal Generator
CapitalBio EcoSampler™
Related patents
- Methods for improving efficiency of cell electroporation using dielectrophoreses
- A testing method of nucleic acid binding protein based on biochip
- Laser confocal microarray scanner
- High speed scanning platform for microarray scanner
- Optical systems for microarray scanning
- Integrated microarray devices
- Microarray devices having controllable reaction volume
- Methods, microarray, and kits for detection of drug resistance genes in gram-negative bacteria
- Chemical amplification electrochemical detecting method for affinity reaction and agent case thereof
- Asymmetrical PCR amplification method, dedicated primer and use thereof
- Trace amount liquid jet system
- High flux biochip and application thereof
- Biochip based method for detecting nucleic acid conjugated protein